DexCom Inc. (DXCM)
NASDAQ
Closed
Oct 9, 2026
Day's Range
82.9452 wk Range
54.11Profile - DXCM - DexCom Inc.
Profile
Mic Code
XNGS
Sector
Healthcare
Industry
Medical Devices
Employees
11K
DexCom Inc. is a medical device company focused on continuous glucose monitoring systems for diabetes and metabolic health. Dexcom develops wearable biosensors, transmitters, receivers, and software that provide real-time glucose readings, trend data, and alerts to help users and clinicians monitor glucose levels without routine fingerstick testing. Its current product lineup includes Dexcom G7, Dexcom G7 15 Day, Dexcom G6, Dexcom ONE+, Stelo, Dexcom Share, and Dexcom Follow, along with digital tools and remote monitoring features that support daily diabetes management. The company serves people with diabetes, adults with prediabetes and type 2 diabetes who do not use insulin, and healthcare professionals across the United States and international markets. Headquartered in San Diego, California, DexCom plays a significant role in the diabetes care technology market through its focus on connected glucose sensing and data-sharing solutions.
Profile Details
Type
Common Stock
Address
6340 Sequence Drive
City
San Diego
State
CA
Zip
92121
Country
United States
Phone
858 200 0200
Key Executives - DXCM - DexCom Inc.
Key executives
Cross Listings - DXCM - DexCom Inc.
Also listed on
The same company trading on other exchanges.
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
